These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 26208605

  • 21. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes.
    Ogawa N, Minamimura K, Kodaka T, Maki T.
    J Autoimmun; 2006 Jun; 26(4):225-31. PubMed ID: 16713179
    [Abstract] [Full Text] [Related]

  • 22. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo.
    Tonkin DR, He J, Barbour G, Haskins K.
    J Immunol; 2008 Oct 01; 181(7):4516-22. PubMed ID: 18802054
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Combination Therapy Using IL-2/IL-2 Monoclonal Antibody Complexes, Rapamycin, and Islet Autoantigen Peptides Increases Regulatory T Cell Frequency and Protects against Spontaneous and Induced Type 1 Diabetes in Nonobese Diabetic Mice.
    Manirarora JN, Wei CH.
    J Immunol; 2015 Dec 01; 195(11):5203-14. PubMed ID: 26482409
    [Abstract] [Full Text] [Related]

  • 25. Role of L-selectin in the development of autoimmune diabetes in non-obese diabetic mice.
    Mora C, Grewal IS, Wong FS, Flavell RA.
    Int Immunol; 2004 Feb 01; 16(2):257-64. PubMed ID: 14734611
    [Abstract] [Full Text] [Related]

  • 26. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS, Jun HS, Utsugi T, Yoon JW.
    J Autoimmun; 1997 Jun 01; 10(3):299-307. PubMed ID: 9218758
    [Abstract] [Full Text] [Related]

  • 27. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse.
    Sobel DO, Yankelevich B, Goyal D, Nelson D, Mazumder A.
    Diabetes; 1998 Feb 01; 47(2):186-91. PubMed ID: 9519711
    [Abstract] [Full Text] [Related]

  • 28. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
    Saï P, Senecat O, Martignat L, Gouin E.
    Clin Exp Immunol; 1994 Jul 01; 97(1):138-45. PubMed ID: 8033411
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
    Esensten JH, Lee MR, Glimcher LH, Bluestone JA.
    J Immunol; 2009 Jul 01; 183(1):75-82. PubMed ID: 19535634
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interleukin-10 gene transfer into insulin-producing β cells protects against diabetes in non-obese diabetic mice.
    Xu A, Zhu W, Li T, Li X, Cheng J, Li C, Yi P, Liu L.
    Mol Med Rep; 2015 Sep 01; 12(3):3881-3889. PubMed ID: 25998958
    [Abstract] [Full Text] [Related]

  • 34. MicroRNA 26a modulates regulatory T cells expansion and attenuates renal ischemia-reperfusion injury.
    Liang S, Wang W, Gou X.
    Mol Immunol; 2015 Jun 01; 65(2):321-7. PubMed ID: 25728641
    [Abstract] [Full Text] [Related]

  • 35. The role of CD8+ cells, cell degeneration, and Fas ligand in insulitis after intraperitoneal transfer of NOD splenocytes.
    Sainio-Pöllänen S, Liukas A, Pöllänen P, Simell O.
    Pancreas; 1999 Apr 01; 18(3):282-93. PubMed ID: 10206487
    [Abstract] [Full Text] [Related]

  • 36. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
    Arai T, Moriyama H, Shimizu M, Sasaki H, Kishi M, Okumachi Y, Yasuda H, Hara K, Yokono K, Nagata M.
    Clin Immunol; 2010 Jul 01; 136(1):74-82. PubMed ID: 20359955
    [Abstract] [Full Text] [Related]

  • 37. IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes.
    Calderon B, Suri A, Pan XO, Mills JC, Unanue ER.
    J Immunol; 2008 Nov 15; 181(10):6964-74. PubMed ID: 18981116
    [Abstract] [Full Text] [Related]

  • 38. Fibroblast Cell-Based Therapy for Experimental Autoimmune Diabetes.
    Jalili RB, Zhang Y, Hosseini-Tabatabaei A, Kilani RT, Khosravi Maharlooei M, Li Y, Salimi Elizei S, Warnock GL, Ghahary A.
    PLoS One; 2016 Nov 15; 11(1):e0146970. PubMed ID: 26765526
    [Abstract] [Full Text] [Related]

  • 39. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
    Mori Y, Kodaka T, Kato T, Kanagawa EM, Kanagawa O.
    Int Immunol; 2009 Nov 15; 21(11):1291-9. PubMed ID: 19778991
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppressive therapy exacerbates autoimmunity in NOD mice and diminishes the protective activity of regulatory T cells.
    Kaminitz A, Mizrahi K, Yaniv I, Stein J, Askenasy N.
    J Autoimmun; 2010 Sep 15; 35(2):145-52. PubMed ID: 20638242
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.